Ambrx Biopharma Statistics Share Statistics Ambrx Biopharma has 63.29M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 63.29M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 21.92M Failed to Deliver (FTD) Shares 848 FTD / Avg. Volume 0.04%
Short Selling Information The latest short interest is 713.65K, so 0% of the outstanding
shares have been sold short.
Short Interest 713.65K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -1.12 and the forward
PE ratio is null.
Ambrx Biopharma's PEG ratio is
0.03.
PE Ratio -1.12 Forward PE n/a PS Ratio 11.84 Forward PS n/a PB Ratio 0.74 P/FCF Ratio -1.26 PEG Ratio 0.03
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Ambrx Biopharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 5.44,
with a Debt / Equity ratio of 0.1.
Current Ratio 5.44 Quick Ratio 5.21 Debt / Equity 0.1 Debt / EBITDA -0.21 Debt / FCF -0.17 Interest Coverage -58.97
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $85.08K Profits Per Employee $-896.51K Employee Count 87 Asset Turnover 0.05 Inventory Turnover n/a
Taxes Income Tax 1.94M Effective Tax Rate -2.55%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is -2.36, so Ambrx Biopharma's
price volatility has been lower than the market average.
Beta -2.36 52-Week Price Change n/a 50-Day Moving Average 25.33 200-Day Moving Average 15.99 Relative Strength Index (RSI) 82.2 Average Volume (20 Days) 1,943,941
Income Statement In the last 12 months, Ambrx Biopharma had revenue of 7.4M
and earned -78M
in profits. Earnings per share was -2.02.
Revenue 7.4M Gross Profit 7.4M Operating Income -57.08M Net Income -78M EBITDA -55.79M EBIT -64.46M Earnings Per Share (EPS) -2.02
Full Income Statement Balance Sheet The company has 55.61M in cash and 11.98M in
debt, giving a net cash position of 43.63M.
Cash & Cash Equivalents 55.61M Total Debt 11.98M Net Cash 43.63M Retained Earnings -291.63M Total Assets 271.5M Working Capital 215.55M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -68.67M
and capital expenditures -1.05M, giving a free cash flow of -69.73M.
Operating Cash Flow -68.67M Capital Expenditures -1.05M Free Cash Flow -69.73M FCF Per Share -1.81
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -771.16% and -1053.72%.
Gross Margin 100% Operating Margin -771.16% Pretax Margin -1027.55% Profit Margin -1053.72% EBITDA Margin -753.69% EBIT Margin -771.16% FCF Margin -942.03%
